Supervised Consumption Sites
They're the most divisive idea in harm reduction: places where people use drugs under supervision so an overdose can be reversed on the spot. At one site, staff reversed 763 overdoses without a single death. Here's what the evidence shows.
Battling addiction & ready for help?
What Supervised Consumption Sites Are
A supervised consumption site is a place where someone can use drugs they already have while trained staff stand by, ready to act the moment an overdose begins. The aim is narrow and immediate: keep a person breathing through the minutes when an overdose would otherwise turn fatal, with naloxone and a trained responder already in the room. Of every tool in harm reduction, this is the most argued-over, which is exactly why the measured version of the subject is worth more than the loud one. Conviction tends to run ahead of proof here, and earning the trust of a skeptical reader matters more than winning the argument.
These sites do not supply drugs and do not exist to make using comfortable. A person brings what they already have; staff provide a monitored space, a fast response if breathing slows or stops, and, at most sites, testing, wound care, naloxone to carry, and a referral into treatment. That last part is the part that matters most, and the part everything here keeps returning to.
Watching someone overdose? You can save a life. What to do right now, before anything else.
- Call 911 first. Say where you are and that someone isn’t breathing. You will not get in trouble for trying to save a life.
- Give naloxone (Narcan) if it’s there. It only works on opioids, it cannot hurt someone who doesn’t need it, and it buys time until medics arrive. Give a second dose after 2 to 3 minutes if there’s no response.
- Help them breathe and stay with them. Roll them onto their side, tilt the chin to open the airway, and do not leave them alone.
- When the dust settles, get help started. You can find treatment near you or get matched with the right care. SAMHSA’s free, confidential helpline is 1-800-662-HELP (4357), 24/7. For thoughts of suicide, call or text 988.
- The evidence is encouraging but thin and lopsided. The most thorough systematic review found 22 studies, and 16 of them centered on a single site in Vancouver, Canada, with outcomes measured too inconsistently to combine into one number[1].
- The on-site overdose-reversal record is strong. In one Vancouver site’s records, all 763 people who arrived unresponsive and not breathing from a witnessed opioid overdose were revived on-site with oxygen and naloxone, none died there, and none needed chest compressions[2].
- A population-level life-saving effect is not proven. The Vancouver cohort most often cited tied frequent use to a lower risk of death from any cause (adjusted hazard ratio 0.46), but as a single-site observational study it cannot show the site caused the difference[3].
- ASAM supports these sites only as pilots. It backs them as treatment-integrated experiments meant to generate the U.S. data that does not yet exist, with funding that does not come at treatment’s expense[4].
- No randomized trial exists. Evaluations rest on observational designs, which is why the field’s strongest claims stay hedged[5].
ASAM Supports Supervised Consumption Sites Only as Pilots
The American Society of Addiction Medicine, the main body of physicians who treat addiction, is no opponent of harm reduction. It endorses naloxone and clean-syringe access outright. On supervised consumption it is deliberately more careful, and that caution is the spine of an honest position on these sites. ASAM supports these sites only as pilots, set up specifically to generate the U.S. data that does not yet exist, with each site integrated with evidence-based addiction treatment, staff trained to link people to that treatment, and funding that does not come at treatment’s expense[4]. Read plainly, even the field’s gold-standard clinical body treats these sites as treatment-tied experiments, not proven life-savers. We hold the same line a half-step more cautiously, and that is an honest place to stand.
What the Research on Supervised Consumption Sites Shows
The research is encouraging, but it is thin and lopsided, and saying so plainly is the point. The most thorough systematic review to date pulled together 22 studies, and 16 of them examined a single site in Vancouver, Canada. The reviewers found these sites mostly associated with fewer overdose harms, better access to addiction treatment, and no rise in crime or public disorder nearby, but the outcomes were measured so inconsistently across studies that they could not be combined into a single pooled number[1]. That is not a case against the idea; it is the state of the evidence. A separate review of how these sites have been studied found the work rests on observational designs, ecological comparisons, cohorts, surveys, and cost models, with no randomized trial yet run, which holds the formal strength of the evidence low[5]. Promising is the right word for it. Proven is not.
Most of what the world knows comes from one city. In the most thorough review of these sites, 16 of the 22 studies examined a single facility in Vancouver, Canada[1]. That lopsidedness is exactly why ASAM wants U.S. pilots, to find out whether one Canadian site’s results hold up somewhere else[4].
On-Site Overdose Reversals Are Real, but Population Evidence Is Not Settled
Two very different claims get blurred together in this debate, and keeping them apart is where the honesty lives. The first is narrow and well supported: when an overdose happens inside one of these sites, staff reverse it. In one Vancouver site’s records, 763 people arrived unresponsive and not breathing after a witnessed opioid overdose, and every one of them was revived on-site with oxygen and naloxone, none died there, and none even needed chest compressions[2]. That is a genuine, repeatable result, and it is the strongest single thing the field can say.
The second claim is far bigger: that these sites lower the overall death rate across a community. That one is not settled. The study cited most often for it followed people who inject drugs in Vancouver and found that frequent users of the site had a lower risk of dying from any cause, less than half the risk after adjustment[3]. But the authors were careful, and so are we. It is a single-site, observational study that cannot prove the site caused the difference, because people who use a site frequently may differ from those who do not in ways no statistic fully captures. On-site reversals are real. A population-level life-saving effect is plausible and unproven, and we will not dress it up as more than that.
Does Supervised Consumption Divert Money From Treatment?
This is a fair question, and it deserves a straight answer rather than a defensive one. If a community spends limited dollars on a place to use drugs more safely, is it pulling money and attention away from the treatment that actually ends addiction? The cleanest answer comes from ASAM’s own conditions: a supervised consumption site should be tied to evidence-based treatment, and its funding should not reduce the resources that pay for that treatment[4]. Held to that bar, the worry stops being a trap and becomes a test. A site that meets it adds a doorway to care. A site that fails it, a place to use with no real path out, is the version of harm reduction we do not support. When researchers interviewed community stakeholders across four U.S. counties hit hard by opioids, people saw possible benefits but also feared the sites might enable use, and they wanted strong evidence and a clear treatment connection before backing them[6]. Those are the right questions to ask, not signs of a hard heart.
Why a Supervised Consumption Site Must Be Tied to Treatment
Strip away the politics and the case for these sites rests entirely on what happens after the overdose is reversed. A rescue that sends someone back to the same street with nothing changed has bought a day, not a life. The whole value is in the connection: the person now breathing is a person in contact with staff who can offer naloxone to carry, testing, wound care, and the part that matters most, a fast link to medication and treatment. The first publicly recognized U.S. sites opened in New York in 2021 inside existing syringe programs, precisely so a moment of contact could become a doorway to services rather than a dead end[7]. Their legal footing in the United States remains unsettled and contested[8][1]. But the principle is not complicated. The medications that treat opioid use disorder, methadone and buprenorphine, are among the strongest tools in the entire field, tied directly to lower death rates after an overdose[9], and any site worth supporting exists to move people toward them. Naloxone keeps a person alive in the moment; treatment is what changes the road they are on.
Where Supervised Consumption Sites Lead
Strip everything else away and the measure of a supervised consumption site is simple: does it move people toward a life free from the drug, or does it leave them parked in front of it? Staying alive is the starting line, never the finish. The destination is recovery, a life free of drugs and alcohol, and harm reduction earns its place only as the bridge that gets a person there alive, never as a substitute for the crossing. If you or someone you love is using, the way out is not as far or as brutal as it feels from here. Detox under medical supervision keeps withdrawal safe, and medication makes it far gentler than the agony most people are bracing for. That is the path, and it is more survivable than going it alone. When you are ready, find treatment near you or get matched with the right help.
If you or someone you love is in immediate danger or having thoughts of suicide, call or text 988 to reach the Suicide and Crisis Lifeline, or call 911.
The next step doesn’t have to be a big one. Our treatment centers directory can point you to the right level of care. Reaching out today is a real step forward — and one you can make right now.
Frequently asked questions
What is a supervised consumption site?
A supervised consumption site is a monitored space where a person can use drugs they already have while trained staff stand ready to reverse an overdose. The same service goes by several names, including overdose prevention center, drug consumption room, and supervised injection facility. The sites do not supply drugs; their job is to keep someone breathing through the dangerous minutes of an overdose and, at most sites, to connect that person to testing, naloxone, and treatment. They are the most contested tool in harm reduction, and the evidence behind them is still being built[1].
Are supervised consumption sites proven to save lives?
Not at the population level, not yet, and we will not claim otherwise. On-site, the overdose-reversal record is strong: in one Vancouver site’s records, all 763 people who arrived unresponsive and not breathing from a witnessed opioid overdose were revived, and none died there[2]. The bigger claim, that these sites lower a community’s overall death rate, is unsettled. The most-cited cohort tied frequent use to a lower risk of dying (adjusted hazard ratio 0.46), but as a single-site observational study it cannot prove the site caused the difference[3]. The reversals are real; the population-level life-saving effect is plausible but not proven.
Does ASAM support supervised consumption sites?
Only as pilots, and with strict conditions. The American Society of Addiction Medicine, the main body of physicians who treat addiction, supports supervised consumption sites as treatment-integrated experiments meant to generate the U.S. data that does not yet exist, with staff trained to link people to evidence-based treatment and funding that does not come at treatment’s expense[4]. Even the field’s gold-standard clinical body treats these sites as careful experiments, not proven life-savers, which is why we hold the same line a half-step more cautiously.
Do supervised consumption sites increase crime or drug use nearby?
The available studies do not show that. In the most thorough systematic review, supervised consumption sites were associated with no increase, or with reductions, in crime and public disorder in the surrounding area[1]. The worry that the sites enable more drug use is common and worth taking seriously, especially among communities considering one, but the evidence to date does not bear it out[6]. The honest caveat is that this evidence is observational and concentrated in a few locations, so it is reasonable to want stronger, local data before drawing firm conclusions.
Are supervised consumption sites legal in the United States?
Their legal status is unsettled and contested. Supervised consumption sites are widely considered illegal under U.S. federal law, even as several cities have moved to open them anyway[1]. A federal court fight over a planned Philadelphia site left the question unresolved[8], and in 2021 New York City supported the opening of the first two publicly recognized U.S. sites, housed inside existing syringe programs and opened only after a careful assessment of legal risk[7]. The legal ground remains shifting and varies by jurisdiction.
How is a supervised consumption site different from treatment?
A supervised consumption site is not treatment, and it should never be sold as one. It is a place to survive an overdose and, ideally, a doorway into care. Treatment is what changes the road a person is on, and the strongest treatments for opioid use disorder, methadone and buprenorphine, are tied directly to lower death rates after an overdose[9]. That is why any site worth supporting must be wired into treatment, with staff who link people to medication and recovery, as ASAM requires[4]. Harm reduction keeps a person alive; treatment is what is on the other side of the door.
Get Treatment Help
If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.
Exclusive offer: 20% Off BetterHelp*Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.
- Fact-Checked
- Editor
